APA (7th ed.) Citation

JJ, G., R, O., & M, Z. (2021). Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients. Frontiers in oncology, 11, 664794. https://doi.org/10.3389/fonc.2021.664794

Chicago Style (17th ed.) Citation

JJ, García-Trejo, Ortega R, and Zarco-Zavala M. "Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients." Frontiers in Oncology 11 (2021): 664794. https://doi.org/10.3389/fonc.2021.664794.

MLA (9th ed.) Citation

JJ, García-Trejo, et al. "Putative Repurposing of Lamivudine, a Nucleoside/Nucleotide Analogue and Antiretroviral to Improve the Outcome of Cancer and COVID-19 Patients." Frontiers in Oncology, vol. 11, 2021, p. 664794, https://doi.org/10.3389/fonc.2021.664794.